Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy
Objective: to analyze the safety of rituximab (RTM) in children with various rheumatic diseases.Materials and methods. The retrospective study included 81 pediatric patients with a confirmed diagnosis of rheumatic disease. Data on the safety of RTM were analyzed for all patients who received at leas...
Main Authors: | M. I. Kaleda, I. P. Nikishina, E. V. Nikolaeva, A. N. Shapovalenko, E. S. Fedorov, T. N. Pachkoria |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2021-05-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3024 |
Similar Items
-
B cell depletion in immune-mediated rheumatic diseases and coronavirus disease 2019 (COVID-19)
by: E. L. Nasonov, et al.
Published: (2021-09-01) -
Rituximab and COVID-19 infection in patients with autoimmune rheumatic diseases – A real-world study from India
by: Aswin M Nair, et al.
Published: (2023-01-01) -
Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases
by: Natalia Riva, et al.
Published: (2022-01-01) -
Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024-02-01) -
Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease
by: Joshua R. Francis, et al.
Published: (2016-01-01)